Cytovation_Logo_Twitter-02-res.png
Cytovation Announces Appointment of Ellen Lubman, MBA to its Board of Directors
20 déc. 2023 03h00 HE | Cytovation
Bergen, Norway, December 20, 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy CyPep-1, today...